A study of over 2 million U.S. patients found GLP-1 drugs such as Ozempic and Wegovy linked to a 29% higher risk of chronic cough, even after excluding GERD cases. The association persists despite the drugs' popularity for diabetes and weight loss. Researchers call for more studies on this unexpected side effect amid expanding GLP-1 uses.